Search Within

Mark E Robson

Formats
  1. Journal Article (383)
  2. Meeting Abstract (262)
  3. Review (11)
  4. Book Section (7)
  5. Guidelines (7)
  6. Editorial (6)
  7. Miscellaneous (4)
  8. Correspondence (1)
  9. Research Letter (1)
Groups
  1. Breast Medicine Service (682)
  2. Department of Medicine (682)
  3. Population Sciences Research Program (682)
  4. Solid Tumor Oncology Division (682)
  5. Survivorship Research (682)
  6. GSK Faculty (379)

More Groups

People
  1. Kenneth Offit (280)
  2. Zsofia Stadler (116)
  3. Larry Norton (90)
  4. Vijai Joseph (79)
  5. Diana Mandelker (74)
  6. Michael Berger (67)

More People

Years
  1. 2025 (7)
  2. 2024 (33)
  3. 2023 (41)
  4. 2022 (34)
  5. 2021 (46)
  6. 2020 (65)

More Years

Publications
  1. Journal of Clinical Oncology (166)
  2. Cancer Research (50)
  3. Breast Cancer Research and Treatment (33)
  4. JNCI: Journal of the National Cancer Institute (20)
  5. Annals of Oncology (19)
  6. Clinical Cancer Research (17)

More Publications

Publishers
  1. American Society of Clinical Oncology (188)
  2. American Association for Cancer Research (82)
  3. Springer (66)
  4. Nature Publishing Group (60)
  5. Oxford University Press (43)
  6. Elsevier Inc. (42)

More Publishers

Results (682)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The optimal living and wellness program: Piloting a novel survivorship care model
    Meeting Abstract

    Corcoran, S.; Russell, J.; Smith, A.; Kelly, B.; Clayton, J.; Stein, B.; Keenan, K.; Robson, M. E.; Iyengar, N. M.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Evaluating the association between clonal hematopoiesis and germline pathogenic and likely pathogenic variants in cancer predisposition genes
    Meeting Abstract

    Comen, E. A.; Razavi, P.; Patel, P. B.; Martin, A.; Seshan, V. E.; Mandelker, D.; Ptashkin, R.; Kemel, Y.; Stadler, Z. K.; Ladanyi, M.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Characterization of patients with multiple primary tumors
    Meeting Abstract

    Cadoo, K. A.; Mukherjee, S.; Khurram, A.; Kemel, Y.; Tkachuk, K.; Liu, Y. L.; Carlo, M. I.; Walsh, M. F.; Latham, A.; Dubard-Gault, M. E.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Disparities in work status after treatment for breast cancer: A controlled, longitudinal study
    Meeting Abstract

    Blinder, V. S.; Patil, S.; Eberle, C.; Jung, G.; Kampel, L. J.; Hwang, C.; Bao, T.; Robson, M. E.; Malik, M.; Gany, F.
    Cancer Epidemiology Biomarkers and Prevention (2020)

    Fulltext@MSK | Save
  • A phase II/III, open-label, randomized trial of pembrolizumab + olaparib vs. pembrolizumab + chemotherapy after induction with pembrolizumab plus chemotherapy in locally recurrent inoperable or metastatic triple-negative breast cancer: KEYLYNK-009
    Meeting Abstract

    Rugo, H. S.; Llombart Cussac, A.; André, F.; Robson, M.; Saji, S.; Harbeck, N.; Schmid, P.; Cescon, D. W.; Seok Ahn, J.; Nanda, R.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Clinical and pathologic features associated with PD-L1 (SP142) expression in stromal tumor-infiltrating immune cells of triple-negative breast carcinoma
    Journal Article

    Hoda, R. S.; Brogi, E.; Dos Anjos, C. H.; Grabenstetter, A.; Ventura, K.; Patil, S.; Selenica, P.; Weigelt, B.; Reis-Filho, J. S.; Traina, T.; more...
    Modern Pathology (2020)

    Fulltext@MSK | Save
  • Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: A report from the ESMO Precision Medicine Working Group
    Review

    Mosele, F.; Remon, J.; Mateo, J.; Westphalen, C. B.; Barlesi, F.; Lolkema, M. P.; Normanno, N.; Scarpa, A.; Robson, M.; Meric-Bernstam, F.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • The genomic landscape of metastatic histologic special types of invasive breast cancer
    Journal Article

    Pareja, F.; Ferrando, L.; Lee, S. S. K.; Beca, F.; Selenica, P.; Brown, D. N.; Farmanbar, A.; Da Cruz Paula, A.; Vahdatinia, M.; Zhang, H.; more...
    npj Breast Cancer (2020)

    Fulltext@MSK | Save
  • Mutation rates in cancer susceptibility genes in patients with breast cancer with multiple primary cancers
    Journal Article

    Maxwell, K. N.; Wenz, B. M.; Kulkarni, A.; Wubbenhorst, B.; D’Andrea, K.; Weathers, B.; Goodman, N.; Vijai, J.; Lilyquist, J.; Hart, S. N.; more...
    JCO Precision Oncology (2020)

    Fulltext@MSK | Save
  • Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants
    Journal Article

    Barnes, D. R.; Rookus, M. A.; McGuffog, L.; Leslie, G.; Mooij, T. M.; Dennis, J.; Mavaddat, N.; Adlard, J.; Ahmed, M.; Aittomäki, K.; more...
    Genetics in Medicine (2020)

    Fulltext@MSK | Save